Crescent Pharma Limited
04750933
Some Concerns
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
- 5 outstanding charges (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 01/05/2003
ENGINEER
BRITISH · ENGLAND · Age 60
Also on 6 other boards
director · Since 07/06/2023
DIRECTOR
BRITISH · UNITED KINGDOM · Age 36
Also on 4 other boards
director · Since 07/06/2023
DIRECTOR
BRITISH · ENGLAND · Age 34
Also on 7 other boards
Persons with Significant Control
Mr Mohammed Khalid Aldoori
British · England · Age 60
Key House, Sarum Hill, Basingstoke, RG21 8SR
Notified 06/04/2016
Crescent Pharmaceuticals Limited
Key House, Sarum Hill, Basingstoke, RG21 8SR
Reg: 07117426 · Companies House · Limited Company By Shares
Notified 29/01/2024
Charges5 outstanding
HSBC UK BANK PLC
HSBC UK BANK PLC
HSBC INVOICE FINANCE (UK) LIMITED
HSBC INVOICE FINANCE (UK) LIMITED
HSBC UK BANK PLC
RBS INVOICE FINANCE LTD
NATIONAL WESTMINSTER BANK PLC
CompanyRankvs 58+ SIC 21100 peers62
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the director with respect to going concern are de
Key FinancialsYear ending 31/12/2021
Turnover
£96.5M
Annual revenue
Net Worth
£23.2M
Balance sheet strength
Cash
£3.0M
Cash in the bank
Profit Before Tax
£349k
Bottom line earnings
Net Current Assets
£20.4M
Working capital
Current Assets
£69.9M
Current Liabilities
£49.5M
Fixed Assets
£2.9M
Debtors
£21.6M
Cost of Sales
£70.1M
Gross Profit
£26.3M
Admin Expenses
£11.4M
Operating Profit
£449k
Profit After Tax
£1.3M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2021 | 1.41 | -£6.0M |
| 2020 | 1.52 | — |
Derived from filed accounts. Not audited figures.